Browse
Search
1997 S Health - Consolidated Contract between The State of NC as Represented by the State Health Director
OrangeCountyNC
>
Board of County Commissioners
>
Contracts and Agreements
>
General Contracts and Agreements
>
1990's
>
1997
>
1997 S Health - Consolidated Contract between The State of NC as Represented by the State Health Director
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/12/2013 12:57:00 PM
Creation date
7/23/2013 9:17:06 AM
Metadata
Fields
Template:
BOCC
Date
5/21/1997
Meeting Type
Regular Meeting
Document Type
Contract
Agenda Item
8g
Document Relationships
Agenda - 05-21-1997 - 8g
(Linked To)
Path:
\Board of County Commissioners\BOCC Agendas\1990's\1997\Agenda - 05-21-1997
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
59
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Page 2 <br /> Contract Addendum <br /> B. Breast Screening and Follow-Up: <br /> 1. Protocols <br /> Protocols for breast screening and follow-up will be in accordance with Breast Health: A Guide <br /> for Health Departments, (DEHNR, October, 1994). <br /> 2. Screening <br /> a. All women will receive instruction in self breast examination (SBE). <br /> b. All women aged 20 - 39 years will receive a clinical breast examination (CBE) every three <br /> years. Women in the high risk group for breast cancer, beginning at age 30, may receive a <br /> CBE screening every year.** <br /> c. All women aged 40 -49 years will receive a CBE every year and a screening <br /> mammogram every other year.** <br /> d. All women aged 50 years and older will receive a CBE and screening mammogram <br /> every year. <br /> ** A woman at high risk for breast cancer may receive a screening mammogram every year. <br /> High risk definitions are found in Breast Health- A Guide for Health Departments, page 3. <br /> 3. Follow-Up <br /> Women having an abnormal breast screening result will be referred for additional evaluation. <br /> BCCCP funds may be.used for the following diagnostic services: <br /> a. Repeat or diagnostic mammogram (including cone-down view); <br /> b. Consultation Visits for Surgical Evaluation; <br /> c. Fine needle aspiration (FNA) and pathology, if needed; <br /> d. Office visits for surgical evaluation and/or FNA; and <br /> e. Breast ultrasound, when preceded by a screening mammogram and in accordance with the <br /> Breast Health_guidelines. <br /> The contractor will assure that a referral system for the diagnosis and treatment of all abnormal <br /> findings is in place. The contractor will designate a person who will be responsible for <br /> implementing a protocol which ensures, to the best of its ability, that all patients receive follow-up <br /> services or medical treatment when required. For all abnormal mammogram and clinical breast <br /> examination results the following information will be documented and reported to the BCCCP <br /> within 60 days of the initial screening date: <br /> a. Follow-up appointment information (date and follow-up location); <br /> b. Patient contact information (number and date of attempts made to follow-up); and <br /> c. Referral information (date and referral source). <br />
The URL can be used to link to this page
Your browser does not support the video tag.